TREATMENT OF DEPRESSION ASSOCIATED WITH CEREBROVASCULAR DISEASE (ACCORDING TO THE DATA OF THE RESONANCE RUSSIAN MULTICENTER NATURALISTIC STUDY)


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Eighty-eight patients with depression and comorbid cerebrovascular disease were treated with Valdoxan (25-50 mg/day) in the Resonance Russian multicenter naturalistic study. Following 6-week therapy, depressive symptomatology was relieved in the vast majority (82.35%) of patients. 17-item Hamilton Depression Rating Scale (HAMD-17) scores decreased from 15.8±3.6 to 5.0±2.7 (p<0.00001). There was also a reduction in the intractable symptoms of depression (fatigability, low work efficiency, dyssomnia) and their negative impact on patient functioning.

全文:

受限制的访问

作者简介

O. Vorobyeva

I.M. Sechenov First Moscow State Medical University

Email: oworobeva@mail.ru
Professor MD

参考

  1. Alexopoulos G., Meyers B., Young R. et al. Vasculardepression’ hypothesis // Arch. Gen. Psychiatry. - 1997; 54: 915-22.
  2. Krishnan K., Hays J., Blazer D. MRI-defined vascular depression // Am. J. Psychiatry. 1997; 154: 497-501.
  3. Navarro V., Gasto C., Lomena F. et al. Normalization of frontal cerebral perfusion in remitted elderly major depression: a 12-month follow-up SPECT study // Neuroimage. - 2002; 16: 781-7.
  4. Kusumi I., Koyama T., Yamashita I. Serotonin-stimulated Ca2+ response in increased in the blood platelets of depressed patients // Biol. Psychiatry. - 1991; 30: 310-2.
  5. Sapolsky R. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders // Arch. Gen. Psychiatry. - 2000; 57: 925-35.
  6. Jonathan W. Strong Tie Links Depression, Stroke, but What's Binding Them? // Psychiatric. News. - 2011; 46: 2-23.
  7. Everson S., Roberts R., Goldberg D. et al. Depressive symptoms and increased risk of stroke mortality over a 29-year period // Arch. Intern. Med. - 1998; 158: 1133-8.

补充文件

附件文件
动作
1. JATS XML
##common.cookie##